Skip to main content

Table 1

From: Systemic alendronate prevents resorption of necrotic bone during revascularization. A bone chamber study in rats

  total bone volume host bone volume graft bone volume
alendr, high dose 70% (sd 18) 37% (sd 15) 34% (sd 5)
contr, high dose 27% (sd 13) 19% (sd 9) 8% (sd 4)
  (p = 0.0002) (p = 0.005) (p = 0.0002)
alendr, low dose 29% (sd 11) 24% (sd 9) 5% (sd 2)
contr, low dose 18% (sd 9) 15% (sd 8) 3% (sd 3)
  (p = 0.049) n.s. (p = 0.037)
not implanted grafts (ref [7])   38% (sd 10)
\